State of Wisconsin Investment Board’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Other funds holding BHVN
LIP
KCM
BC
BTI
FIA
IA
MSCM
State of Wisconsin Investment Board's BHVN Position: Q4 2022 in Review
State of Wisconsin Investment Board sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 61,357 shares — an estimated $9.28M sold.
State of Wisconsin Investment Board first reported a position in BHVN in Q3 2017 and held it in 20 quarters. The position peaked at $23.4M in Q4 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.
- State of Wisconsin Investment Board reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
- State of Wisconsin Investment Board sold 61,357 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $9.28M.
- State of Wisconsin Investment Board first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 20 quarters.
- State of Wisconsin Investment Board's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $23.4M in Q4 2021.
- 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.
Based on State of Wisconsin Investment Board's 13F filing for Q4 2022, filed 14 Feb 2023.